Your browser doesn't support javascript.
loading
HLAII peptide presentation of infliximab increases when complexed with TNF.
Casasola-LaMacchia, Andrea; Seward, Robert Joseph; Tourdot, Sophie; Willetts, Matthew; Kruppa, Gary; Agostino, Michael J; Bergeron, Gabrielle; Ahyi-Amendah, Nathalie; Ciarla, Andrew; Lu, Zhaojiang; Kim, Hai-Young; Hickling, Timothy P; Neubert, Hendrik.
Afiliación
  • Casasola-LaMacchia A; BioMedicine Design, Worldwide Research, Development and Medical, Pfizer Inc., Andover, MA, United States.
  • Seward RJ; BioMedicine Design, Worldwide Research, Development and Medical, Pfizer Inc., Andover, MA, United States.
  • Tourdot S; BioMedicine Design, Worldwide Research, Development and Medical, Pfizer Inc., Andover, MA, United States.
  • Willetts M; Bruker Daltonics, Billerica, MA, United States.
  • Kruppa G; Bruker Daltonics, Billerica, MA, United States.
  • Agostino MJ; Pfizer Digital, Pfizer Inc., Andover, MA, United States.
  • Bergeron G; BioMedicine Design, Worldwide Research, Development and Medical, Pfizer Inc., Andover, MA, United States.
  • Ahyi-Amendah N; BioMedicine Design, Worldwide Research, Development and Medical, Pfizer Inc., Andover, MA, United States.
  • Ciarla A; BioMedicine Design, Worldwide Research, Development and Medical, Pfizer Inc., Andover, MA, United States.
  • Lu Z; Analytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., Andover, MA, United States.
  • Kim HY; Analytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc., Andover, MA, United States.
  • Hickling TP; BioMedicine Design, Worldwide Research, Development and Medical, Pfizer Inc., Andover, MA, United States.
  • Neubert H; BioMedicine Design, Worldwide Research, Development and Medical, Pfizer Inc., Andover, MA, United States.
Front Immunol ; 13: 932252, 2022.
Article en En | MEDLINE | ID: mdl-36177046

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Epítopos de Linfocito T / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Epítopos de Linfocito T / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos